Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2015

01.01.2015 | Original Research

Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients

verfasst von: M. L. Maia, C. S. Pereira, G. Melo, I. Pinheiro, M. A. Exley, G. Porto, M. F. Macedo

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Invariant natural killer T (iNKT) cells are CD1d restricted-T cells that react to lipid antigens. iNKT cells were shown to be important in infection, autoimmunity and tumor surveillance. Alterations in the number and function of these cells were described in several pathological conditions including autoimmune and/or liver diseases. CD1d is critical for antigen presentation to iNKT cells, and its expression is increased in liver diseases. The liver is the major organ affected in Hereditary Hemochromatosis (HH), an autosomal recessive disorder caused by excessive iron absorption. Herein, we describe the study of iNKT cells of HH patients.

Methods

Twenty-eight HH patients and 24 control subjects from Santo António Hospital, Porto, were included in this study. Patient’s iron biochemical parameters (serum transferrin saturation and ferritin levels) and the liver function marker alanine transaminase (ALT) were determined at the time of study. Peripheral blood iNKT cells were analyzed by flow cytometry using an anti-CD3 antibody and the CD1d tetramer loaded with PBS57.

Results

We found a decrease in the percentage and number of circulating iNKT cells from HH patients when compared with control population independently of age. iNKT cell defects were more pronounced in untreated patients, relating with serum ferritin and transferrin saturation levels. No correlation was found with ALT, a marker of active liver dysfunction.

Conclusions

Altogether, our results demonstrate that HH patients have reduced numbers of iNKT cells and that these are influenced by iron overload.
Literatur
1.
Zurück zum Zitat Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11:197–206.PubMedCrossRef Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11:197–206.PubMedCrossRef
2.
Zurück zum Zitat Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11:131–42.PubMedCrossRef Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11:131–42.PubMedCrossRef
3.
Zurück zum Zitat De Libero G, Mori L. How the immune system detects lipid antigens. Prog Lipid Res. 2010;49:120–7.PubMedCrossRef De Libero G, Mori L. How the immune system detects lipid antigens. Prog Lipid Res. 2010;49:120–7.PubMedCrossRef
4.
Zurück zum Zitat Lynch L, O’Shea D, Winter DC, Geoghegan J, Doherty DG, O’Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol. 2009;39:1893–901.PubMedCrossRef Lynch L, O’Shea D, Winter DC, Geoghegan J, Doherty DG, O’Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol. 2009;39:1893–901.PubMedCrossRef
5.
Zurück zum Zitat Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489–93.PubMedCentralPubMedCrossRef Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489–93.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Montoya CJ, Cataño JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008;127:1–6.PubMedCrossRef Montoya CJ, Cataño JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008;127:1–6.PubMedCrossRef
7.
Zurück zum Zitat Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He X-S, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002;123:1031–43.PubMedCrossRef Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He X-S, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002;123:1031–43.PubMedCrossRef
8.
Zurück zum Zitat Lucas M, Gadola S, Meier U, Young NT, Harcourt G, Karadimitris A, et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol. 2003;77:2251–7.PubMedCentralPubMedCrossRef Lucas M, Gadola S, Meier U, Young NT, Harcourt G, Karadimitris A, et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol. 2003;77:2251–7.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Exley MA, Koziel MJ. To be or not to be NKT: natural killer T cells in the liver. Hepatology. 2004;40:1033–40.PubMedCrossRef Exley MA, Koziel MJ. To be or not to be NKT: natural killer T cells in the liver. Hepatology. 2004;40:1033–40.PubMedCrossRef
10.
Zurück zum Zitat Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002;109:131–40.PubMedCentralPubMedCrossRef Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002;109:131–40.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Driver JP, Scheuplein F, Chen Y-G, Grier AE, Wilson SB, Serreze DV. Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes. 2010;59:423–32.PubMedCentralPubMedCrossRef Driver JP, Scheuplein F, Chen Y-G, Grier AE, Wilson SB, Serreze DV. Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes. 2010;59:423–32.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001;100:144–8.PubMedCrossRef Van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001;100:144–8.PubMedCrossRef
13.
Zurück zum Zitat Bollyky PL, Wilson SB. CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Immunol. Cell Biol. 2004;307–14. Bollyky PL, Wilson SB. CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Immunol. Cell Biol. 2004;307–14.
14.
Zurück zum Zitat De Libero G, Collmann A, Mori L. The cellular and biochemical rules of lipid antigen presentation. Eur J Immunol. 2009;39:2648–56.PubMedCrossRef De Libero G, Collmann A, Mori L. The cellular and biochemical rules of lipid antigen presentation. Eur J Immunol. 2009;39:2648–56.PubMedCrossRef
15.
Zurück zum Zitat Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, Afdhal N, et al. Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells. J Immunol. 2004;173:2159–66.PubMedCrossRef Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, Afdhal N, et al. Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells. J Immunol. 2004;173:2159–66.PubMedCrossRef
16.
Zurück zum Zitat Brossay L, Jullien D, Cardell S, Sydora BC, Burdin N, Modlin RL, et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol. 1997;159:1216–24.PubMed Brossay L, Jullien D, Cardell S, Sydora BC, Burdin N, Modlin RL, et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol. 1997;159:1216–24.PubMed
17.
Zurück zum Zitat Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology. 1993;80:561–5.PubMedCentralPubMed Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology. 1993;80:561–5.PubMedCentralPubMed
18.
19.
20.
Zurück zum Zitat Gton CAW, Ley KVK. Review article: haemochromatosis. Aliment Pharmacol Ther. 2002;1963–75. Gton CAW, Ley KVK. Review article: haemochromatosis. Aliment Pharmacol Ther. 2002;1963–75.
21.
Zurück zum Zitat Porto G, Cardoso CS, Gordeuk V, Cruz E, Fraga J, Areias J, et al. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur J Haematol. 2001;67:110–8.PubMedCrossRef Porto G, Cardoso CS, Gordeuk V, Cruz E, Fraga J, Areias J, et al. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur J Haematol. 2001;67:110–8.PubMedCrossRef
22.
Zurück zum Zitat Arosa FA, Oliveira L, Porto G, da Silva BM, Kruijer W, Veltman J, et al. Anomalies of the CD8+ T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8 + CD28- T cells. Clin Exp Immunol. 1997;107:548–54.PubMedCentralPubMedCrossRef Arosa FA, Oliveira L, Porto G, da Silva BM, Kruijer W, Veltman J, et al. Anomalies of the CD8+ T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8 + CD28- T cells. Clin Exp Immunol. 1997;107:548–54.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Porto B, Vieira R, Porto G. Increased capacity of lymphocytes from hereditary hemochromatosis patients homozygous for the C282Y HFE mutation to respond to the genotoxic effect of diepoxybutane. Mutat Res. 2009;673:37–42.PubMedCrossRef Porto B, Vieira R, Porto G. Increased capacity of lymphocytes from hereditary hemochromatosis patients homozygous for the C282Y HFE mutation to respond to the genotoxic effect of diepoxybutane. Mutat Res. 2009;673:37–42.PubMedCrossRef
24.
Zurück zum Zitat Cruz E, Vieira J, Almeida S, Lacerda R, Gartner A, Cardoso CS, et al. A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Med Genet. 2006;7:16.PubMedCentralPubMedCrossRef Cruz E, Vieira J, Almeida S, Lacerda R, Gartner A, Cardoso CS, et al. A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Med Genet. 2006;7:16.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat De Sousa M, Porto G. The immunological system in hemochromatosis. J Hepatol. 1998;28 Suppl 1:1–7.PubMedCrossRef De Sousa M, Porto G. The immunological system in hemochromatosis. J Hepatol. 1998;28 Suppl 1:1–7.PubMedCrossRef
26.
Zurück zum Zitat Macedo MF, Porto G, Costa M, Vieira CP, Rocha B, Cruz E. Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells. Clin Exp Immunol. 2010;159:363–71.PubMedCentralPubMedCrossRef Macedo MF, Porto G, Costa M, Vieira CP, Rocha B, Cruz E. Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells. Clin Exp Immunol. 2010;159:363–71.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol. 2007;42:719–32.PubMedCrossRef Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol. 2007;42:719–32.PubMedCrossRef
28.
Zurück zum Zitat Peralbo E, DelaRosa O, Gayoso I, Pita ML, Tarazona R, Solana R. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology. 2006;7:483–92.PubMedCrossRef Peralbo E, DelaRosa O, Gayoso I, Pita ML, Tarazona R, Solana R. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology. 2006;7:483–92.PubMedCrossRef
29.
Zurück zum Zitat Reuben A, Phénix M, Santos MM, Lapointe R. The WT hemochromatosis protein HFE inhibits CD8+ T-lymphocyte activation. Eur J Immunol. 2014;44:1604–14.PubMedCrossRef Reuben A, Phénix M, Santos MM, Lapointe R. The WT hemochromatosis protein HFE inhibits CD8+ T-lymphocyte activation. Eur J Immunol. 2014;44:1604–14.PubMedCrossRef
30.
Zurück zum Zitat Niemelä O, Parkkila S, Britton RS, Brunt E, Janney C, Bacon B. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J Lab Clin Med. 1999;133:451–60.PubMedCrossRef Niemelä O, Parkkila S, Britton RS, Brunt E, Janney C, Bacon B. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J Lab Clin Med. 1999;133:451–60.PubMedCrossRef
31.
Zurück zum Zitat Salio M, Silk JD, Cerundolo V. Recent advances in processing and presentation of CD1 bound lipid antigens. Curr Opin Immunol. 2010;22:81–8.PubMedCrossRef Salio M, Silk JD, Cerundolo V. Recent advances in processing and presentation of CD1 bound lipid antigens. Curr Opin Immunol. 2010;22:81–8.PubMedCrossRef
32.
Zurück zum Zitat Myers BM, Prendergast FG, Holman R, Kuntz SM, LaRusso NF. Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload. J Clin Invest. 1991;88:1207–15.PubMedCentralPubMedCrossRef Myers BM, Prendergast FG, Holman R, Kuntz SM, LaRusso NF. Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload. J Clin Invest. 1991;88:1207–15.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol. 2009;51:845–52.PubMedCentralPubMedCrossRef Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol. 2009;51:845–52.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002;97:1–4.PubMedCrossRef Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002;97:1–4.PubMedCrossRef
Metadaten
Titel
Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients
verfasst von
M. L. Maia
C. S. Pereira
G. Melo
I. Pinheiro
M. A. Exley
G. Porto
M. F. Macedo
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2015
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0118-0

Weitere Artikel der Ausgabe 1/2015

Journal of Clinical Immunology 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.